Skip to main content
Ch. 24 - Cancer Genetics

Chapter 23, Problem 28

The table in this problem summarizes some of the data that have been collected on mutations in the BRCA1 tumor-suppressor gene in families with a high incidence of both early-onset breast cancer and ovarian cancer.

Predisposing Mutations in BRCA1
Kindred    Codon    Nucleotide     Coding Effect     Frequency in
                               Change                                    Control
                                                                                Chromosomes    
 1901          24           -11 bp          Frameshift           0/180
                                                       or splice
 2082        1313         C→T           Gln→Stop            0/170
 1910        1756         Extra C        Frameshift           0/162
 2099        1775         T→G            Met→Arg            0/120
 2035         NA*          ?                  Loss of                NA*
                                                       transcript                                      _
Source: (1994). Science 266:66–71. © AAAS.

Note the coding effect of the mutation found in kindred group 2082. This results from a single base-pair substitution. Draw the normal double-stranded DNA sequence for this codon (with the 5' and 3' ends labeled), and show the sequence of events that generated this mutation, assuming that it resulted from an uncorrected mismatch event during DNA replication.

Verified Solution
Video duration:
2m
This video solution was recommended by our tutors as helpful for the problem above.
275
views
Was this helpful?

Video transcript

Hey everyone, let's take a look at this question together. Which of the following statements about B. R. C. A. Gene mutations is true. So let's recall what we've learned about that B. R. C. A. Gene mutation. To try to figure out which of these following statements are true. So what are some things we know about that B. R. C. A. Gene mutation? So we know that having that gene mutation does not mean that the patient has breast or ovarian cancer, but it means that they have a higher risk or cancer compared to those who don't have that mutation in the B. R. C. A. Gene. And we also know that when we conduct that test to see if there are mutations in that B. R. C. A gene, that negative test outcome does not mean you are safe. And what this means is even though the test result comes back negative, it is possible that that mutation is not detectable. So, a negative test doesn't necessarily mean that you are not at risk because of that possibility that that gene mutation is not detectable. So it is important to investigate the family history to give an accurate diagnosis, which means that answer choice C. Is a true statement regarding that B. R. C. A. G mutation. Because in answer choice A it says all women with the gene mutation have breast cancer. And answer choice. B says all women with that mutation have ovarian cancer, which we know is not true because if you have that gene mutation, it does not mean that you have breast or ovarian cancer. It just implies that there is that higher risk of having that breast or ovarian cancer. So answer choice is A and B. Are not true statements. And then answer choice D. Says that the neck gene test means that a woman is safe from breast cancer, which we know is also not true because that negative test does not mean you are safe. It could mean that the gene is undetectable by the test, which is why you should investigate the family history of breast cancer to see if you have that higher risk. So answer choice C is a true statement and is the correct answer to this question. I hope you found this video to be helpful. Thank you and goodbye.
Related Practice
Textbook Question

A study by Bose and colleagues [(1998). Blood 92:3362–3367] and a previous study by Biernaux and others [(1996). Bone Marrow Transplant 17:(Suppl. 3) S45–S47] showed that BCR-ABL fusion gene transcripts can be detected in 25 to 30 percent of healthy adults who do not develop chronic myelogenous leukemia (CML). Explain how these individuals can carry a fusion gene that is transcriptionally active and yet do not develop CML.

232
views
Textbook Question

Those who inherit a mutant allele of the RB1 tumor-suppressor gene are at risk for developing a bone cancer called osteosarcoma. You suspect that in these cases, osteosarcoma requires a mutation in the second RB1 allele, and you have cultured some osteosarcoma cells and obtained a cDNA clone of a normal human RB1 gene. A colleague sends you a research paper revealing that a strain of cancer-prone mice develop malignant tumors when injected with osteosarcoma cells, and you obtain these mice. Using these three resources, what experiments would you perform to determine (a) whether osteosarcoma cells carry two RB1 mutations, (b) whether osteosarcoma cells produce any pRB protein, and (c) if the addition of a normal RB1 gene will change the cancer-causing potential of osteosarcoma cells?

257
views
Textbook Question

What evidence indicates that mutations in human DNA mismatch repair genes are related to certain forms of cancer?

269
views
Textbook Question

The table in this problem summarizes some of the data that have been collected on mutations in the BRCA1 tumor-suppressor gene in families with a high incidence of both early-onset breast cancer and ovarian cancer.

Predisposing Mutations in BRCA1
Kindred    Codon    Nucleotide     Coding Effect     Frequency in
                               Change                                    Control
                                                                                Chromosomes    
 1901          24           -11 bp          Frameshift           0/180
                                                       or splice
 2082        1313         C→T           Gln→Stop            0/170
 1910        1756         Extra C        Frameshift           0/162
 2099        1775         T→G            Met→Arg            0/120
 2035         NA*          ?                  Loss of                NA*
                                                       transcript                                      _
Source: (1994). Science 266:66–71. © AAAS.

Examine the types of mutations that are listed in the table, and determine if the BRCA1 gene is likely to be a tumor-suppressor gene or an oncogene.

213
views
Textbook Question

The table in this problem summarizes some of the data that have been collected on mutations in the BRCA1 tumor-suppressor gene in families with a high incidence of both early-onset breast cancer and ovarian cancer.

Predisposing Mutations in BRCA1
Kindred    Codon    Nucleotide     Coding Effect     Frequency in
                               Change                                    Control
                                                                                Chromosomes    
 1901          24           -11 bp          Frameshift           0/180
                                                       or splice
 2082        1313         C→T           Gln→Stop            0/170
 1910        1756         Extra C        Frameshift           0/162
 2099        1775         T→G            Met→Arg            0/120
 2035         NA*          ?                  Loss of                NA*
                                                       transcript                                      _
Source: (1994). Science 266:66–71. © AAAS.

Although the mutations listed in the table are clearly deleterious and cause breast cancer in women at very young ages, each of the kindred groups had at least one woman who carried the mutation but lived until age 80 without developing cancer. Name at least two different mechanisms (or variables) that could underlie variation in the expression of a mutant phenotype, and propose an explanation for the incomplete penetrance of this mutation. How do these mechanisms or variables relate to this explanation?

252
views
Textbook Question

Researchers have identified some tumors that have no recurrent mutations or deletions in known oncogenes or tumor-suppressor genes and no detectable epigenetic alterations. However, these tumors often have large chromosomal deletions. What are some possible explanations that could account for the genetic causes behind these tumors?

217
views